Phong Phu Pharmaceutical JSC (HNX:PPP)
Vietnam · Delayed Price · Currency is VND 18,400
-300 (-1.60%)
At close: Apr 24, 2026
HNX:PPP Revenue
In the year 2025, Phong Phu Pharmaceutical JSC had annual revenue of 139.74B VND with 1.59% growth. Phong Phu Pharmaceutical JSC had revenue of 41.26B in the quarter ending December 31, 2025, with 13.03% growth.
Revenue
139.74B
Revenue Growth
+1.59%
P/S Ratio
1.16
Revenue / Employee
659.15M
Employees
212
Market Cap
161.92B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 139.74B | 2.19B | 1.59% |
| Jan 1, 2025 | 137.55B | -14.62B | -9.61% |
| Jan 1, 2024 | 152.17B | 1.60B | 1.06% |
| Dec 31, 2022 | 150.57B | 17.29B | 12.97% |
| Dec 31, 2021 | 133.29B | 17.03B | 14.65% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Vidipha Central Pharmaceutical JSC | 971.25B |
| Ben Tre Pharmaceutical JSC | 860.31B |
| Vimedimex Medi-Pharma JSC | 812.98B |
| Pharmedic Pharmaceutical Medicinal JSC | 546.57B |
| Central Pharmaceutical Joint Stock Company No3 | 481.09B |
| Mediplantex National Pharmaceutical JSC | 366.83B |
| Lamdong Pharmaceutical JSC | 243.91B |
| SPM Corporation | 217.45B |